These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7677339)

  • 21. Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.
    Evans RG; Anderson WP
    Br J Pharmacol; 1995 Sep; 116(1):1557-70. PubMed ID: 8564219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interaction of rilmenidine with renal imidazoline-guanidine sites].
    Lachaud V; Bidet M; Coupry I; Podevin RA; Poujeol P; Parini A
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():15-8. PubMed ID: 2576516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain structures involved in the hypotensive effects of rilmenidine: evaluation by [14C]2-deoxyglucose autoradiography.
    Macrae IM; Browne SE
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S55-8. PubMed ID: 8642807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. I1 receptors, cardiovascular function, and metabolism.
    Bousquet P
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):317S-321S. PubMed ID: 11721890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethanol counteraction of I1-imidazoline but not alpha-2 adrenergic receptor-mediated reduction in vascular resistance in conscious spontaneously hypertensive rats.
    El-Mas MM; Abdel-Rahman AA
    J Pharmacol Exp Ther; 1999 Feb; 288(2):455-62. PubMed ID: 9918545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection of focal ischemic infarction by rilmenidine in the animal: evidence that interactions with central imidazoline receptors may be neuroprotective.
    Reis DJ; Regunathan S; Golanov EV; Feinstein DL
    Am J Cardiol; 1994 Dec; 74(13):25A-30A. PubMed ID: 7998581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site and receptors involved in the sympathoinhibitory actions of rilmenidine.
    Head GA; Burke SL; Chan CK
    J Hypertens Suppl; 1998 Aug; 16(3):S7-12. PubMed ID: 9747904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of rilmenidine on baroreflex control of renal sympathetic nerve activity.
    Sannajust F; Head GA
    J Hypertens Suppl; 1993 Dec; 11(5):S328-9. PubMed ID: 7908964
    [No Abstract]   [Full Text] [Related]  

  • 29. Apparent absence of direct renal effect of imidazoline receptor agonists.
    Smyth DD; Pirnat D; Forzley B; Penner SB
    Ann N Y Acad Sci; 2003 Dec; 1009():288-95. PubMed ID: 15028602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The imidazoline-guanidinium receptor site, a target for some alpha-2 adrenergic agonists, is involved in inhibition of Na(+)-H+ exchange in renal proximal tubule cells.
    Bidet M; Poujeol P; Parini A
    J Hypertens Suppl; 1991 Dec; 9(6):S216-7. PubMed ID: 1687868
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X.
    Velliquette RA; Kossover R; Previs SF; Ernsberger P
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):300-12. PubMed ID: 16416266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different affinities of alpha 2-agonists for imidazoline and alpha 2-adrenergic receptors.
    Coupry I; Lachaud V; Podevin RA; Koenig E; Parini A
    Am J Hypertens; 1989 Jun; 2(6 Pt 1):468-70. PubMed ID: 2569318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha(2A)-adrenergic versus imidazoline receptor controversy in rilmenidine's action: alpha(2A)-antagonism in humans versus alpha(2A)-agonism in rabbits.
    Molderings GJ; Bonisch H; Bruss M; Gothert M
    Ann N Y Acad Sci; 2003 Dec; 1009():279-82. PubMed ID: 15028600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular studies of alpha-2-adrenoceptor and catecholamine-insensitive imidazoline-receptor binding sites using [3H]-rilmenidine in rat brain and kidney.
    King PR; Suzuki S; Nero TL; Gundlach AL; Louis WJ
    J Hypertens Suppl; 1993 Dec; 11(5):S160-1. PubMed ID: 7908962
    [No Abstract]   [Full Text] [Related]  

  • 36. Imidazoline receptors. A new concept in central regulation of the arterial blood pressure.
    Bousquet P; Feldman J; Tibirica E; Bricca G; Greney H; Dontenwill M; Stutzmann J; Belcourt A
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):47S-50S. PubMed ID: 1350728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moxonidine displays a presynaptic alpha-2-adrenoceptor-dependent synergistic sympathoinhibitory action at imidazoline-1 receptors.
    Schäfer U; Burgdorf C; Engelhardt A; Raasch W; Kurz T; Richardt G
    Ann N Y Acad Sci; 2003 Dec; 1009():265-9. PubMed ID: 15028597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central cardiovascular effects of rilmenidine and neuropeptide Y in the conscious spontaneously hypertensive rat: haemodynamic and biochemical evidence for a negative interaction.
    McAuley MA; Reid JL; Macrae IM
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):945-52. PubMed ID: 1376817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1999 Jun; 881():279-86. PubMed ID: 10415926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible role of NMDA receptors in antinociception induced by rilmenidine in mice in the formalin test.
    Sabetkasaie M; Khansefid N; Ladgevardi MA
    Eur J Pain; 2007 Jul; 11(5):535-41. PubMed ID: 16934506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.